CREDIT AGREEMENT

Name: Starling Oncology, Inc. CREDIT AGREEMENT
Creator: CovenantTerminal

Signed Jul 1, 2026

Committed: n/a
Matures: Jul 2031
Agent: OrbiMed Opportunities (CA) V LLC

Tranche	Size	Matures	Margin
Term Loan B	n/a	Jul 2031	575 bps

Priced over SOFR, floor 300 bps (Term Loan B).

Level	Condition	Margin	Unused fee
Level all	all times	575 bps	n/a

§3.4

Lenders: OrbiMed Opportunities (CA) V LLC

CovenantTestedHeadroomLimit now

Tested monthlyHeadroom not yet measured700,000,000

Commencing with the month ending December 31, 2027, and for each month thereafter, the Net Revenue for the most recently ended period of twelve consecutive months shall not be less than $700,000,000.

Read the filing on sec.gov ↗

Download CSV · Download JSON

Amendments

No amendments on file yet.

Report an error

Email [email protected].